| Anthony Lim, MD | |
|
155 N Fresno St, Fresno, CA 93701-2302 | |
| (559) 499-6440 | |
| Not Available |
| Full Name | Anthony Lim |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 155 N Fresno St, Fresno, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477058675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 164965 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
In a SciDev.Net letter to the editor, Rashid Zargar from the Centre of Research for Development at the University of Kashmir, responds to an editorial published by the news service last week in which editor David Dickson suggested that "focusing on the science and technology required to eliminate a disease, rather than just control it, can pay off."
NeoGraft is pleased to announce the selection of Verasoni Worldwide as integrated marketing communications partner. NeoGraft is a world leader in hair replacement technology serving physicians and patients in the United States and around the world. NeoGraft is the first Class One FDA Listed automated medical device for hair restoration.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.
› Verified 6 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
In a SciDev.Net letter to the editor, Rashid Zargar from the Centre of Research for Development at the University of Kashmir, responds to an editorial published by the news service last week in which editor David Dickson suggested that "focusing on the science and technology required to eliminate a disease, rather than just control it, can pay off."
NeoGraft is pleased to announce the selection of Verasoni Worldwide as integrated marketing communications partner. NeoGraft is a world leader in hair replacement technology serving physicians and patients in the United States and around the world. NeoGraft is the first Class One FDA Listed automated medical device for hair restoration.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.
› Verified 6 days ago
| Entity Name | San Joaquin Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588960413 PECOS PAC ID: 6305022047 Enrollment ID: O20110516000103 |
News Archive
In a SciDev.Net letter to the editor, Rashid Zargar from the Centre of Research for Development at the University of Kashmir, responds to an editorial published by the news service last week in which editor David Dickson suggested that "focusing on the science and technology required to eliminate a disease, rather than just control it, can pay off."
NeoGraft is pleased to announce the selection of Verasoni Worldwide as integrated marketing communications partner. NeoGraft is a world leader in hair replacement technology serving physicians and patients in the United States and around the world. NeoGraft is the first Class One FDA Listed automated medical device for hair restoration.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Lim, MD 155 N Fresno St, Fresno, CA 93701-2302 Ph: () - | Anthony Lim, MD 155 N Fresno St, Fresno, CA 93701-2302 Ph: (559) 499-6440 |
News Archive
In a SciDev.Net letter to the editor, Rashid Zargar from the Centre of Research for Development at the University of Kashmir, responds to an editorial published by the news service last week in which editor David Dickson suggested that "focusing on the science and technology required to eliminate a disease, rather than just control it, can pay off."
NeoGraft is pleased to announce the selection of Verasoni Worldwide as integrated marketing communications partner. NeoGraft is a world leader in hair replacement technology serving physicians and patients in the United States and around the world. NeoGraft is the first Class One FDA Listed automated medical device for hair restoration.
In her "Global Health Blog," Guardian health editor Sarah Boseley speaks with GlaxoSmithKline CEO Andrew Witty about the year-long efforts to bring together the heads of more than a dozen pharmaceutical companies in a large public-private initiative to control or eliminate neglected tropical diseases.
The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.
› Verified 6 days ago
Michelle Lea Storkan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Harminder S Longia, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-225-6100 | |
Dr. Jessie Werner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Megann Forrest Young, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 Fax: 559-499-6441 | |
Geoffrey R Stroh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 Fax: 559-499-6441 | |
Marc Stanley Shalit, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6439 Fax: 559-499-6441 | |
Dr. Patil Armenian, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 |